Recent Advances in the Exploitation of Cell Surface Receptors for Targeted Cell Therapies
The past decade has witnessed significant expansion in both preclinical and approved receptor-targeted therapeutic cell modalities. These include immune cells engineered to express chimeric antigen receptors (CARs), and bispecific immune cell engagers developed for the treatment of cancer, autoimmune disorders, infecti...